Who is seeking pharmacotherapy treatment for opioid dependence? Annual data examines who, where and why on a ‘snapshot day’ in 2020, and how treatment has progressed.
GP webinar series: The neurobiology of weight change The upcoming Rethink Obesity webcast will give GPs insight into leveraging pharmacotherapy and behavioural therapy for weight management.
How one US doctor made a change to help tackle America’s opioid crisis When this emergency doctor was unable to help a patient experiencing addiction, he looked deeper.
Renewed calls to fully subsidise methadone treatment GPs and addiction experts fear hidden costs are preventing more people from accessing treatment.
Should GPs be able to prescribe buprenorphine without restriction? As Australia battles a spike in opioid-related deaths, research suggests advantages in much greater availability of pharmacotherapy treatment.
Age of opioid pharmacotherapy patients increasing, report says The median age of opioid pharmacotherapy patients is increasing, according to a recent Australian Institute of Health and Welfare report.